Comments
Loading...
Latest Capricor Therapeutics Stock News | NASDAQ:CAPR | Benzinga
Get the latest news on Capricor Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Capricor Therapeutics performance
Categories: All
Monday, March 10, 2025
Tuesday, March 04, 2025
- HC Wainwright & Co. Reiterates Buy on Caprico...
- Capricor Therapeutics Cell Therapy Goes Under Priority FDA Review For Duchenne Associated-Heart Condition
- Market-Moving News for March 4th
- Capricor Therapeutics shares are trading high...
- Capricor Says FDA Granted Deramiocel BLA Prio...
- Capricor Says FDA Accepted For Review Its Bio...
Wednesday, January 08, 2025
Thursday, January 02, 2025
Thursday, December 05, 2024
Wednesday, November 20, 2024
Monday, November 18, 2024
Thursday, November 14, 2024
Wednesday, November 13, 2024
Tuesday, November 12, 2024
Wednesday, October 23, 2024
Monday, October 21, 2024
Thursday, October 17, 2024
Wednesday, October 16, 2024
Friday, October 11, 2024
- $1000 Invested In This Stock 5 Years Ago Would Be Worth $6,800 Today
- Capricor Therapeutics Says Duchenne Muscular Dystrophy Candidate Shows Sustained Cardiac, Skeletal Benefits After 3 Years
- Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday
- Capricor Therapeutics shares are trading high...
- Capricor Therapeutics Reports Long-Term Data ...
- HC Wainwright & Co. Maintains Buy on Capricor...